NATIONAL ORGANIZATION FOR RARE DISORDERS, INC. (NORD) for NATIONAL ORGANIZATION FOR RARE DISORDERS INC (NORD)
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Rare Disease Initiatives. Newborn Screening. Affordable Care Act (ACA) Issues and Enhancements. Telehealth. H.R.2940/S.1355 - PASTEUR Act of 2023.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MASON OLIVER BARRETT New | — |
| HAYLEY DEMPSEY New | — |
| ALLISON HERRITY | — |
Medicare/Medicaid MMM
Medicare / Medicaid issues impacting patients with rare diseases. Inflation Reduction Act Implementation.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MASON OLIVER BARRETT New | — |
| KARIN HOELZER | — |
| HEIDI ROSS | — |
Pharmacy PHA
Pharmaceutical issues impacting patients with rare diseases. Orphan Drug Act. Prescription Drug User Fee Act (PDUFA) Reauthorization. S.1214 - RARE Act. Inflation Reduction Act Implementation.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MASON OLIVER BARRETT New | — |
| HAYLEY DEMPSEY | — |
| KARIN HOELZER | — |
| HEIDI ROSS | — |
Budget/Appropriations BUD
Appropriations impacting patients with rare diseases. Advanced Research Projects Agency - Health (ARPA-H) Appropriations. National Institutes of Health (NIH) NCATS Appropriations.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KARIN HOELZER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.